Status:
UNKNOWN
Choice of Inhalation Device
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Asthma
COPD
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
In this study, asthma and COPD patients will be invited to participate after the consultation with their pulmonologist. The intervention consists of three steps. The first step is to perform a deep i...
Detailed Description
The study will take place in the respiratory outpatient clinic. Patients will be invited to participate in the study after the consultation with the pulmonologist. All pulmonologists have a flowchart ...
Eligibility Criteria
Inclusion
- COPD patients (GOLD II-IV)
- Patients with severe asthma
- Patients with mild-to moderate asthma aged \< 70y
- Patients with asthma aged ≥ 70y
Exclusion
- Patients with asthma or COPD not on inhaled therapy for maintenance treatment
- Patients younger than 18y
- Patients unable to give their informed consent due to mental or physical disability
- Patients who don't speak French or Dutch
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05264441
Start Date
April 1 2022
End Date
June 1 2023
Last Update
March 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.